These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2899638)

  • 1. Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana users.
    Johansson E; Agurell S; Hollister LE; Halldin MM
    J Pharm Pharmacol; 1988 May; 40(5):374-5. PubMed ID: 2899638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana.
    Johansson E; Halldin MM; Agurell S; Hollister LE; Gillespie HK
    Eur J Clin Pharmacol; 1989; 37(3):273-7. PubMed ID: 2558889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
    Manno JE; Manno BR; Kemp PM; Alford DD; Abukhalaf IK; McWilliams ME; Hagaman FN; Fitzgerald MJ
    J Anal Toxicol; 2001 Oct; 25(7):538-49. PubMed ID: 11599597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users.
    Kelly P; Jones RT
    J Anal Toxicol; 1992; 16(4):228-35. PubMed ID: 1323733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans.
    Huestis MA; Cone EJ
    Ther Drug Monit; 1998 Oct; 20(5):570-6. PubMed ID: 9780137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol when normalized to urinary creatinine.
    Beardsley GD; Christensen JM
    Res Commun Mol Pathol Pharmacol; 2007-2008; 120-121(1-6):67-78. PubMed ID: 21469505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users.
    Ohlsson A; Lindgren JE; Wahlén A; Agurell S; Hollister LE; Gillespie HK
    Biomed Mass Spectrom; 1982 Jan; 9(1):6-10. PubMed ID: 6277407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of delta 1-tetrahydrocannabinol in plasma to the low picogram range by gas chromatography-mass spectrometry using metastable ion detection.
    Harvey DJ; Leuschner JT; Paton WD
    J Chromatogr; 1980 Dec; 202(1):83-92. PubMed ID: 6260826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary elimination half-life of delta-1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
    Johansson EK; Hollister LE; Halldin MM
    NIDA Res Monogr; 1989; 95():457-8. PubMed ID: 2561839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
    Johansson E; Halldin MM
    J Anal Toxicol; 1989; 13(4):218-23. PubMed ID: 2550702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GC-MS-MS confirmation of unusually high delta 9-tetrahydrocannabinol levels in two postmortem blood samples.
    Collins M; Easson J; Hansen G; Hodda A; Lewis K
    J Anal Toxicol; 1997; 21(7):538-42. PubMed ID: 9399122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short communication: Urinary excretion of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol in a pregnant woman following heavy, chronic cannabis use.
    Westin AA; Huestis MA; Aarstad K; Spigset O
    J Anal Toxicol; 2009; 33(9):610-4. PubMed ID: 20040136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasensitive measurement of delta-9-tetrahydrocannabinol with a high energy dynode detector and electron-capture negative chemical-ionization mass spectrometry.
    Shaw LM; Edling-Owens J; Mattes R
    Clin Chem; 1991 Dec; 37(12):2062-8. PubMed ID: 1662560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.
    Huestis MA; Mitchell JM; Cone EJ
    J Anal Toxicol; 1996 Oct; 20(6):441-52. PubMed ID: 8889681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
    Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
    Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH).
    Huestis MA; Henningfield JE; Cone EJ
    J Anal Toxicol; 1992; 16(5):283-90. PubMed ID: 1338216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation of cannabis use. III. Simultaneous quantitation of six metabolites of delta 9-tetrahydrocannabinol in plasma by high-performance liquid chromatography with electrochemical detection.
    Nakahara Y; Cook CE
    J Chromatogr; 1988 Dec; 434(1):247-52. PubMed ID: 2854134
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of delta 9-THC on marijuana smoking, dose choice, and verbal report of drug liking.
    Kelly TH; Foltin RW; Emurian CS; Fischman MW
    J Exp Anal Behav; 1994 Mar; 61(2):203-11. PubMed ID: 8169569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid.
    Kauert GF; Ramaekers JG; Schneider E; Moeller MR; Toennes SW
    J Anal Toxicol; 2007 Jun; 31(5):288-93. PubMed ID: 17579974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration.
    Gustafson RA; Kim I; Stout PR; Klette KL; George MP; Moolchan ET; Levine B; Huestis MA
    J Anal Toxicol; 2004 Apr; 28(3):160-7. PubMed ID: 15107145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.